Celularity INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

21 May 2025

CELU

10-K/A: Celularity Files Amendment to 10-K, Providing Detailed Insights into Executive Compensation and Corporate Governance

Celularity Inc. files an amendment to its 2024 annual report on Form 10-K/A, focusing on Part III disclosures related to directors, executive officers, compensation, and corporate governance.

NASDAQ

8 May 2025

CELU

Celularity INC

10-K: Celularity Inc. Reports Fiscal Year 2024 Results, Faces Going Concern Uncertainty

Celularity Inc.'s fiscal year 2024 results reveal a net loss and substantial doubt about its ability to continue as a going concern, despite increased revenues.

NASDAQ

30 Jul 2024

CELU

Celularity INC

10-K: Celularity Inc. 10-K Filing Reveals Financial Struggles Amidst Pipeline Shift

Celularity Inc.'s annual 10-K filing highlights significant net losses, substantial debt, and a strategic pipeline refocus, raising concerns about its ability to continue as a going concern.